174 related articles for article (PubMed ID: 3959692)
1. [Cisplatin ototoxicity. A clinical study].
Schröder M; Laskawi R; Stennert E; Kühnle H; Thiele FW
Laryngol Rhinol Otol (Stuttg); 1986 Feb; 65(2):86-9. PubMed ID: 3959692
[TBL] [Abstract][Full Text] [Related]
2. [Ototoxicity of cisplatin in children with malignant diseases].
Hadjilaskari P; Fengler R; Hartmann R; Henze G
Klin Padiatr; 1989; 201(4):316-21. PubMed ID: 2779137
[TBL] [Abstract][Full Text] [Related]
3. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
[TBL] [Abstract][Full Text] [Related]
4. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
Bertolini P; Lassalle M; Mercier G; Raquin MA; Izzi G; Corradini N; Hartmann O
J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-55. PubMed ID: 15454836
[TBL] [Abstract][Full Text] [Related]
5. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.
Freilich RJ; Kraus DH; Budnick AS; Bayer LA; Finlay JL
Med Pediatr Oncol; 1996 Feb; 26(2):95-100. PubMed ID: 8531860
[TBL] [Abstract][Full Text] [Related]
6. [Monitoring hearing during ototoxic cisplatin therapy].
Kluba J; Kluba U; von Specht H; Mittler U
Padiatr Grenzgeb; 1990; 29(1):19-23. PubMed ID: 2342815
[TBL] [Abstract][Full Text] [Related]
7. [Ototoxic side effects in patients with ovarian cancer treated with cisplatin].
Behling H; Spieske C; Krafft W
Zentralbl Gynakol; 1988; 110(5):277-82. PubMed ID: 3376611
[TBL] [Abstract][Full Text] [Related]
8. [Ototoxicity of cisplatin chemotherapy in patients with ovarian cancer].
Beck E; Schuster M; Berg A; Jäger W; Wildt L; Lang N
Gynakol Rundsch; 1991; 31 Suppl 2():280-5. PubMed ID: 1790954
[No Abstract] [Full Text] [Related]
9. [Hearing loss caused by high dose carboplatin therapy].
Lautermann J; Adamczyk M; ten Cate WJ; Kloke O
Laryngorhinootologie; 1998 Feb; 77(2):82-4. PubMed ID: 9555700
[TBL] [Abstract][Full Text] [Related]
10. [The ototoxicity of the cytostatic drug carboplatin in patients with head-neck tumors].
Bauer FP; Westhofen M; Kehrl W
Laryngorhinootologie; 1992 Aug; 71(8):412-5. PubMed ID: 1388466
[TBL] [Abstract][Full Text] [Related]
11. Aminoglycoside ototoxicity: a human temporal bone study.
Hinojosa R; Nelson EG; Lerner SA; Redleaf MI; Schramm DR
Laryngoscope; 2001 Oct; 111(10):1797-805. PubMed ID: 11801948
[TBL] [Abstract][Full Text] [Related]
12. cis-platinum ototoxicity in children.
Weatherly RA; Owens JJ; Catlin FI; Mahoney DH
Laryngoscope; 1991 Sep; 101(9):917-24. PubMed ID: 1886439
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-induced ototoxicity: audiometric findings and experimental cochlear pathology.
Böheim K; Bichler E
Arch Otorhinolaryngol; 1985; 242(1):1-6. PubMed ID: 4041173
[TBL] [Abstract][Full Text] [Related]
15. Ototoxicity of carboplatin: comparing animal and clinical models at the Hospital for Sick Children.
Macdonald MR; Harrison RV; Wake M; Bliss B; Macdonald RE
J Otolaryngol; 1994 Jun; 23(3):151-9. PubMed ID: 8064951
[TBL] [Abstract][Full Text] [Related]
16. [The ototoxicity of cisplatin: a clinical study].
Vantrappen G; Rector E; Debruyne F
Acta Otorhinolaryngol Belg; 1990; 44(4):415-21. PubMed ID: 2093285
[TBL] [Abstract][Full Text] [Related]
17. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
[TBL] [Abstract][Full Text] [Related]
18. [Changes in transitory evoked otoacoustic emissions in chemotherapy with cisplatin and 5FU].
Beck A; Maurer J; Welkoborsky HJ; Mann W
HNO; 1992 Apr; 40(4):123-7. PubMed ID: 1601678
[TBL] [Abstract][Full Text] [Related]
19. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Rasch CR; Tange RA; Balm AJ; Dreschler WA
Audiol Neurootol; 2006; 11(5):318-30. PubMed ID: 16983183
[TBL] [Abstract][Full Text] [Related]
20. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
